ENOB - Why Enochian BioSciences Was a Winner on Monday
Biotech Enochian BioSciences (NASDAQ: ENOB) enjoyed a nice share price lift on Monday. The small-cap stock rocked 12% higher at one point, although it ultimately cooled down to a 1.2% gain on the day.
That morning, Enochian announced that it had acquired an exclusive license for a novel approach for treating coronaviruses, such as SARS-CoV-2 (the one that causes COVID-19), and influenza.
In the company's words, this technology "tricks the viruses to trigger the cells it infects to commit suicide instead of becoming a virus-making factory."
For further details see:
Why Enochian BioSciences Was a Winner on Monday